• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从多个角度揭示 VASH1 对卵巢癌的抑制作用。

Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives.

机构信息

Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.

出版信息

Cancer Biol Ther. 2023 Dec 31;24(1):2285817. doi: 10.1080/15384047.2023.2285817. Epub 2023 Nov 27.

DOI:10.1080/15384047.2023.2285817
PMID:38010374
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10783835/
Abstract

The function of () in human cancer has not been thoroughly or comprehensively examined. Here, we identified the tumor suppressor part of across cancers, including epithelial ovarian tumors. Our study carefully contrasted the expression of VASH1 in pancancer and nontumorous tissues in a public database to explore its regulatory role in clinical prognosis, diagnosis, tumor purity, and immune cell infiltration. Next, we explored the antitumor mechanism of through drug sensitivity, functional enrichment, and phenotypic experiments in ovarian cancer. Research suggests that the expression of in neoplastic tissues is lower than that in normal tissues. affects the OS and RFS of several tumor types. In addition, expression resulted in a high OS and RFS in the diagnosis of tumor and nontumor tissues and negatively regulated tumor purity. Moreover, controls the tumor microenvironment by regulating immunocyte infiltration. In ovarian cancer, can serve as a biomarker to estimate the efficacy of chemotherapy. Functional enrichment analysis suggests that plays a tumor suppressor role by regulating the extracellular matrix receptor pathway. inhibition of the malignant phenotype of ovarian cancer cells was further confirmed by experiments. These results indicate that acts as a cancer-inhibiting factor and potential therapeutic target in ovarian cancer.

摘要

()在人类癌症中的功能尚未得到彻底或全面的研究。在这里,我们确定了 across cancers 中肿瘤抑制因子的一部分,包括上皮性卵巢肿瘤。我们的研究仔细对比了公共数据库中泛癌和非肿瘤组织中 VASH1 的表达,以探讨其在临床预后、诊断、肿瘤纯度和免疫细胞浸润中的调节作用。接下来,我们通过卵巢癌中的药物敏感性、功能富集和表型实验探索了 的抗肿瘤机制。研究表明,在肿瘤组织中的表达低于在正常组织中的表达。 影响几种肿瘤类型的 OS 和 RFS。此外,在肿瘤和非肿瘤组织的诊断中, 的表达导致高 OS 和 RFS,并负调控肿瘤纯度。此外, 通过调节免疫细胞浸润来控制肿瘤微环境。在卵巢癌中, 可以作为评估化疗疗效的生物标志物。功能富集分析表明, 通过调节细胞外基质受体通路发挥肿瘤抑制作用。 通过实验进一步证实了 抑制卵巢癌细胞恶性表型的作用。这些结果表明, 在卵巢癌中作为一种抑癌因子和潜在的治疗靶点。

相似文献

1
Revealing the inhibitory effect of VASH1 on ovarian cancer from multiple perspectives.从多个角度揭示 VASH1 对卵巢癌的抑制作用。
Cancer Biol Ther. 2023 Dec 31;24(1):2285817. doi: 10.1080/15384047.2023.2285817. Epub 2023 Nov 27.
2
Vasohibin-1 Is a Poor Prognostic Factor of Ovarian Carcinoma.血管抑制素-1是卵巢癌的不良预后因素。
Tohoku J Exp Med. 2017 Oct;243(2):107-114. doi: 10.1620/tjem.243.107.
3
Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.血管抑制素-1的表达抑制了产生多种血管生成因子的卵巢癌的进展。
Cancer Sci. 2016 May;107(5):629-37. doi: 10.1111/cas.12911. Epub 2016 Mar 30.
4
The angiogenesis regulator vasohibin-1 inhibits ovarian cancer growth and peritoneal dissemination and prolongs host survival.血管生成调节因子血管抑制素-1可抑制卵巢癌生长和腹膜播散,并延长宿主生存期。
Int J Oncol. 2015 Dec;47(6):2057-63. doi: 10.3892/ijo.2015.3193. Epub 2015 Oct 8.
5
Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer.ELL 相关因子 2 和血管抑素 1 调控结直肠癌侵袭、迁移和血管生成的机制。
World J Gastroenterol. 2023 Jun 28;29(24):3770-3792. doi: 10.3748/wjg.v29.i24.3770.
6
Vasohibin-1 increases the malignant potential of colorectal cancer and is a biomarker of poor prognosis.血管抑制素-1增强结直肠癌的恶性潜能,是预后不良的生物标志物。
Anticancer Res. 2014 Oct;34(10):5321-9.
7
Vasohibin-1 expression detected by immunohistochemistry correlates with prognosis in non-small cell lung cancer.通过免疫组织化学检测到的血管抑制素-1表达与非小细胞肺癌的预后相关。
Med Oncol. 2014 May;31(5):963. doi: 10.1007/s12032-014-0963-y. Epub 2014 Apr 20.
8
Significance of vasohibin 1 in cancer patients: A systematic review and meta analysis.血管生成素 1 在癌症患者中的意义:系统评价和荟萃分析。
J Cancer Res Ther. 2022 Apr;18(2):567-575. doi: 10.4103/jcrt.jcrt_281_21.
9
Increased vasohibin-1 expression is associated with metastasis and poor prognosis of renal cell carcinoma patients.血管抑肽-1 表达增加与肾细胞癌患者的转移和不良预后相关。
Lab Invest. 2017 Jul;97(7):854-862. doi: 10.1038/labinvest.2017.26. Epub 2017 Mar 13.
10
Tregs are involved in VEGFA/ VASH1-related angiogenesis pathway in ovarian cancer.调节性T细胞参与卵巢癌中血管内皮生长因子A/血管生成抑制因子1相关的血管生成途径。
Transl Oncol. 2023 Jun;32:101665. doi: 10.1016/j.tranon.2023.101665. Epub 2023 Apr 3.

引用本文的文献

1
Vasohibins in Health and Disease: From Angiogenesis to Tumorigenesis, Multiorgan Dysfunction, and Brain-Heart Remodeling.健康与疾病中的血管抑制素:从血管生成到肿瘤发生、多器官功能障碍及脑心重塑
Cells. 2025 May 23;14(11):767. doi: 10.3390/cells14110767.
2
Forced Vasohibin-1 Expression Increases Paclitaxel Sensitivity of Ovarian Cancer by Inhibiting Microtubule Activity.强制表达血管抑制素-1通过抑制微管活性增加卵巢癌对紫杉醇的敏感性。
Cancer Rep (Hoboken). 2024 Dec;7(12):e70100. doi: 10.1002/cnr2.70100.
3
A potential coagulation-related diagnostic model associated with immune infiltration for acute myocardial infarction.

本文引用的文献

1
Oncogenic ACSM1 in prostate cancer is through metabolic and extracellular matrix-receptor interaction signaling pathways.前列腺癌中致癌性ACSM1是通过代谢和细胞外基质-受体相互作用信号通路发挥作用的。
Am J Cancer Res. 2022 Apr 15;12(4):1824-1842. eCollection 2022.
2
Vasohibin-1 and -2 in pulmonary lymphangioleiomyomatosis (LAM) cells associated with angiogenic and prognostic factors.肺动脉平滑肌脂肪瘤(LAM)细胞中的血管生成素-1 和血管生成素-2 与血管生成和预后因素相关。
Pathol Res Pract. 2022 Feb;230:153758. doi: 10.1016/j.prp.2022.153758. Epub 2022 Jan 7.
3
Expression Profiling of Glioblastoma Cell Lines Reveals Novel Extracellular Matrix-Receptor Genes Correlated With the Responsiveness of Glioma Patients to Ionizing Radiation.
一种与急性心肌梗死免疫浸润相关的潜在凝血相关诊断模型。
Genes Immun. 2024 Dec;25(6):471-482. doi: 10.1038/s41435-024-00298-z. Epub 2024 Oct 8.
4
Identification of mitochondria-related gene biomarkers associated with immune infiltration in acute myocardial infarction.急性心肌梗死中与免疫浸润相关的线粒体相关基因生物标志物的鉴定
iScience. 2024 Jun 14;27(7):110275. doi: 10.1016/j.isci.2024.110275. eCollection 2024 Jul 19.
5
mA methylation-mediated regulation of LncRNA MEG3 suppresses ovarian cancer progression through miR-885-5p and the VASH1 pathway.甲基化介导的长链非编码 RNA MEG3 调控通过 miR-885-5p 和 VASH1 通路抑制卵巢癌进展。
J Transl Med. 2024 Jan 29;22(1):113. doi: 10.1186/s12967-024-04929-x.
胶质母细胞瘤细胞系的表达谱分析揭示了与胶质瘤患者对电离辐射反应性相关的新型细胞外基质-受体基因。
Front Oncol. 2021 May 25;11:668090. doi: 10.3389/fonc.2021.668090. eCollection 2021.
4
Systemic immunity in cancer.癌症的系统性免疫。
Nat Rev Cancer. 2021 Jun;21(6):345-359. doi: 10.1038/s41568-021-00347-z. Epub 2021 Apr 9.
5
Tumor-infiltrating dendritic cell states are conserved across solid human cancers.肿瘤浸润树突状细胞状态在实体人类癌症中是保守的。
J Exp Med. 2021 Jan 4;218(1). doi: 10.1084/jem.20200264.
6
Ovarian Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.卵巢癌临床实践指南(2020 年第 2 版),NCCN 肿瘤学临床实践指南
J Natl Compr Canc Netw. 2021 Feb 2;19(2):191-226. doi: 10.6004/jnccn.2021.0007.
7
Connexins and cAMP Cross-Talk in Cancer Progression and Metastasis.癌症进展和转移过程中连接蛋白与环磷酸腺苷的相互作用
Cancers (Basel). 2020 Dec 28;13(1):58. doi: 10.3390/cancers13010058.
8
Tumor-Infiltrating Natural Killer Cells.肿瘤浸润自然杀伤细胞。
Cancer Discov. 2021 Jan;11(1):34-44. doi: 10.1158/2159-8290.CD-20-0655. Epub 2020 Dec 4.
9
Treatment of epithelial ovarian cancer.上皮性卵巢癌的治疗。
BMJ. 2020 Nov 9;371:m3773. doi: 10.1136/bmj.m3773.
10
Multi-dimensional omics characterization in glioblastoma identifies the purity-associated pattern and prognostic gene signatures.胶质母细胞瘤的多组学特征分析确定了与纯度相关的模式和预后基因特征。
Cancer Cell Int. 2020 Jan 31;20:37. doi: 10.1186/s12935-020-1116-3. eCollection 2020.